Legal & General Group’s Aspen Aerogels ASPN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$20.6K Sell
6,035
-61,095
-91% -$206K ﹤0.01% 2950
2025
Q4
$190K Hold
67,130
﹤0.01% 2586
2025
Q3
$467K Hold
67,130
﹤0.01% 2466
2025
Q2
$397K Buy
67,130
+2,324
+4% +$13.4K ﹤0.01% 2505
2025
Q1
$414K Buy
64,806
+1,268
+2% +$12.2K ﹤0.01% 2454
2024
Q4
$755K Buy
63,538
+348
+0.6% +$5.93K ﹤0.01% 2325
2024
Q3
$1.75M Buy
63,190
+4,735
+8% +$118K ﹤0.01% 2036
2024
Q2
$1.39M Buy
58,455
+8,369
+17% +$196K ﹤0.01% 2090
2024
Q1
$882K Buy
50,086
+5,307
+12% +$78.2K ﹤0.01% 2234
2023
Q4
$707K Sell
44,779
-6,538
-13% -$67.5K ﹤0.01% 2330
2023
Q3
$441K Sell
51,317
-470
-0.9% -$3.34K ﹤0.01% 2483
2023
Q2
$409K Buy
51,787
+28,559
+123% +$199K ﹤0.01% 2527
2023
Q1
$173K Buy
23,228
+3,631
+19% +$36.1K ﹤0.01% 2638
2022
Q4
$231K Buy
19,597
+7,679
+64% +$87.8K ﹤0.01% 2553
2022
Q3
$110K Buy
11,918
+1,504
+14% +$18.2K ﹤0.01% 2789
2022
Q2
$103K Buy
10,414
+1,471
+16% +$29.7K ﹤0.01% 2848
2022
Q1
$309K Buy
8,943
+229
+3% +$7.43K ﹤0.01% 2530
2021
Q4
$434K Buy
8,714
+6,418
+280% +$338K ﹤0.01% 2456
2021
Q3
$106K Buy
2,296
+36
+2% +$1.43K ﹤0.01% 2833
2021
Q2
$68K Buy
2,260
+397
+21% +$8.1K ﹤0.01% 2857
2021
Q1
$38K Hold
1,863
﹤0.01% 2906
2020
Q4
$31K Buy
1,863
+62
+3% +$815 ﹤0.01% 2938
2020
Q3
$20K Sell
1,801
-700
-28% -$5.54K ﹤0.01% 2961
2020
Q2
$16K Buy
+2,501
New +$16.1K ﹤0.01% 3149

Other funds holding ASPN

Legal & General Group's ASPN Position: Q1 2026 in Review

Legal & General Group reduced its Aspen Aerogels (ASPN) stake by 91% in Q1 2026, selling an estimated $206K and leaving 6,035 shares worth $20.6K. The position accounts for ﹤0.01% of the portfolio, ranked #2950.

Legal & General Group first reported a position in ASPN in Q2 2020 and has held it in 24 quarters since. The position peaked at $1.75M in Q3 2024. 166 funds tracked by Wall St. Rank hold ASPN as of Q1 2026.

  • Legal & General Group held 6,035 shares of Aspen Aerogels worth $20.6K as of Q1 2026.
  • Legal & General Group sold 61,095 Aspen Aerogels shares in Q1 2026, an estimated $206K.
  • Aspen Aerogels made up ﹤0.01% of Legal & General Group's portfolio in Q1 2026, its #2950 holding.
  • Legal & General Group first reported a position in Aspen Aerogels in Q2 2020 and has held it in 24 quarters since.
  • Legal & General Group's Aspen Aerogels position peaked at $1.75M in Q3 2024.
  • 166 funds tracked by Wall St. Rank held Aspen Aerogels as of Q1 2026.

Based on Legal & General Group's 13F filing for Q1 2026, filed 8 May 2026.